WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY – Get Free Report) shares hit a new 52-week high during trading on Monday . The stock traded as high as $26.50 and last traded at $26.0860, with a volume of 1100 shares trading hands. The stock had previously closed at $25.5575.
Wall Street Analysts Forecast Growth
Separately, Zacks Research raised shares of WuXi AppTec from a “hold” rating to a “strong-buy” rating in a report on Friday, August 7th. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Buy rating to the company. According to MarketBeat.com, WuXi AppTec has an average rating of “Strong Buy”.
Check Out Our Latest Analysis on WuXi AppTec
WuXi AppTec Price Performance
About WuXi AppTec
WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.
Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.
Further Reading
- Five stocks we like better than WuXi AppTec
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
- D-Wave Has Momentum—What Does It Need to Keep It Going?
- TSMC’s Insider Buying Wave Comes With a Bigger AI Question for Investors
Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.
